DHG Pharmaceutical Joint Stock Company (HOSE: DHG)
Health Care · Pharmaceuticals · VN
₫89,200.00
-0.22% today · -12.5% 1Y
DHG Pharmaceutical Joint Stock Company (HOSE: DHG) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $450.55M.
Over the last twelve months the share price has lost 12.5%, trading between 89.10K and 110.00K.
Tweenvest scores DHG Pharmaceutical Joint Stock Company across four factors: quality 88/100, value 83/100, growth 32/100, dividend 100/100. Its strongest factor is dividend.
DHG price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $450.55M
- Revenue (TTM)
- $207.05M
- P/E
- 12.50
- EPS
- 7,133.35
- Dividend yield
- 5.61%
- Beta (5Y)
- 0.25
- 52-week high
- ₫110,000.00
- 52-week low
- ₫89,100.00
- Avg volume (3M)
- —
- Shares outstanding
- 130.75M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Myung In Pharmaceutical LTD.KOSE: A317450 | $462.09M | ₩42,550.00 | -2.52% |
| Shanghai Kai Kai Industry Company LimitedSHSE: 600272 | $461.00M | CN¥15.65 | +4.26% |
| Vireo Growth Inc.CNSX: VREO | $457.48M | CA$13.37 | -2.41% |
| iX Biopharma Ltd.Catalist: 42C | $452.33M | S$0.53 | -5.36% |
| Jiangxi Synergy Pharmaceutical Co., Ltd.SZSE: 300636 | $448.91M | CN¥7.16 | +0.99% |
| JW Pharmaceutical CorporationKOSE: A001060 | $447.47M | ₩26,350.00 | -1.50% |
| AgomAb Therapeutics NVNasdaqGS: AGMB | $447.17M | $9.08 | -1.52% |
| Shaanxi Panlong Pharmaceutical Group Co., Ltd.SZSE: 002864 | $435.73M | CN¥21.35 | +1.43% |
Figures last refreshed Oct 11, 2026.